Equity

Total Equity

Rithm Capital Total Equity remained flat by 0.0% to $8.61B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $7.78B to $8.61B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 9.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 4, 2026

How to read this metric

An increase generally signals growth in retained earnings or capital injections, while a decrease may indicate share buybacks, dividend payments, or net losses.

Detailed definition

This represents the residual interest in the assets of the entity after deducting all its liabilities. It reflects the n...

Peer comparison

Standard across all public companies; peers in the medical device and diagnostics sector typically maintain high equity levels to support R&D and M&A.

Metric ID: total_stockholders_equity

Historical Data

40 periods
 Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25Q3 '25Q3 '25Q4 '25Q4 '25Q1 '26Q1 '26
Value$6.07B$6.07B$6.56B$6.56B$6.60B$6.60B$7.12B$7.12B$6.99B$6.99B$6.99B$6.99B$6.94B$6.94B$6.89B$6.89B$7.13B$7.13B$7.21B$7.21B$7.01B$7.01B$7.15B$7.15B$7.33B$7.33B$7.66B$7.66B$7.79B$7.79B$7.78B$7.78B$7.95B$7.95B$8.50B$8.50B$8.43B$8.43B$8.61B$8.61B
QoQ Change+0.0%+8.0%+0.0%+0.7%+0.0%+7.9%+0.0%-1.8%+0.0%-0.0%+0.0%-0.7%+0.0%-0.7%+0.0%+3.5%+0.0%+1.0%+0.0%-2.8%+0.0%+2.0%+0.0%+2.5%+0.0%+4.5%+0.0%+1.8%+0.0%-0.2%+0.0%+2.2%+0.0%+6.9%+0.0%-0.8%+0.0%+2.1%+0.0%
YoY Change+15.2%+15.2%+6.6%+6.6%+5.1%+5.1%-3.2%-3.2%+2.0%+2.0%+3.1%+3.1%+0.9%+0.9%+3.7%+3.7%+2.7%+2.7%+6.2%+6.2%+11.2%+11.2%+8.8%+8.8%+8.5%+8.5%+11.0%+11.0%+8.2%+8.2%+10.7%+10.7%
Range$6.07B$8.61B
CAGR+3.6%
Avg YoY Growth+6.3%
Median YoY Growth+6.4%
Current Streak3 quarters growth

Business Segments

View all
SegmentQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Origination and Servicing$5.72B$5.53B$5.83B$6.19B$5.58B$5.81B
Corporate Category-$1.22B-$1.26B-$1.05B-$989.58M-$1.14B-$1.29B-$1.33B-$2.22B
Investment Portfolio$1.57B$1.59B$1.61B$1.80B$1.72B$1.62B
Residential Transitional Lending$801.65M$845.63M$820.75M$941.03M$881.48M$934.22M
Total$7.33B$7.66B$7.79B$7.78B$7.95B$8.50B$8.43B$8.61B

Mortgage Loans Receivable, Origination, Residential Securities, Properties and Loans, Servicing were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is Rithm Capital's total equity?
Rithm Capital (RITM) reported total equity of $8.61B in Q1 2026.
How has Rithm Capital's total equity changed year-over-year?
Rithm Capital's total equity increased by 10.7% year-over-year, from $7.78B to $8.61B.
What is the long-term trend for Rithm Capital's total equity?
Over 5 years (2020 to 2025), Rithm Capital's total equity has grown at a 9.6% compound annual growth rate (CAGR), from $5.32B to $8.43B.
What does total equity mean?
The total value of the company that belongs to the shareholders after all debts are paid.